tbuckley/cabot-search huggingface dataset:
Abstract 10940: Outcomes of Ultrasound-accelerated Catheter-directed Thrombolytic Therapy Versus Intravenous Thrombolysis in Pulmonary Embolism Patients---Insights From Nationwide Inpatient Sample
Authors: Tiantian Shi, John-Ross Clarke, Roy Tony, Amarnath Annapureddy, Stuart W Zarich
Journal: Circulation (2019)

Introduction/hypothesis: Ultrasound-accelerated catheter-directed thrombolytic therapy (UA-CDT) improves right ventricular stress more quickly as compared to standard therapy in patients with subma...
1814P Molecular profile and clinical data of patients with lung cancer harboring germline TP53 R337H mutation
Authors: C.D.H. Lopes, F.F. Antonacio;, P.M.G. Moraes, G. Harada, R. Gadia, D.L.F. Jardim, A. Katz, R.L. Sandoval, M.I.A.D.S.W. Achatz, G. de Castro
Journal: Annals of Oncology (2021)
858O Results of KEYNOTE-122: A phase III study of pembrolizumab (pembro) monotherapy vs chemotherapy (chemo) for platinum-pretreated, recurrent or metastatic (R/M) nasopharyngeal carcinoma (NPC)
Authors: A.T. Chan, V.H.F. Lee, R-L. Hong, M-J. Ahn, W.Q. Chong, S-B. Kim, H. Gwo Fuang, P.B. Caguioa, N. Ngamphaiboon, C. Ho, M.A.S. Abdul Aziz, Q.S. Ng, C-J. Yen, N. Soparattanapaisarn, K.C.R. Ngan, S.K. Kho, R. Swaby, S. Saraf, J. Ge, L.L. Siu
Journal: Annals of Oncology (2021)
Facile fabrication of a biocompatible composite gel with sustained release of aspirin for bone regeneration
Authors: Yunfan Zhang, Xueyu Dou, Lingyun Zhang, Hufei Wang, Ting Zhang, Rushui Bai, Qiannan Sun, Xing Wang, Tingting Yu, Decheng Wu, Bing Han, Xuliang Deng
Journal: Bioactive Materials (2021)
Walking and Other Common Physical Activities Among Adults with Arthritis — United States, 2019
Authors: Dana Guglielmo, Louise B. Murphy, Kristina A. Theis, Michael A. Boring, Charles G. Helmick, Kathleen B. Watson, Lindsey M. Duca, Erica L. Odom, Yong Liu, Janet B. Croft
Journal: MMWR Morbidity and Mortality Weekly Report (2021)

The numerous health benefits of physical activity include reduced risk for chronic disease and improved mental health and quality of life (1). Physical activity can improve physical function and reduce pain and fall risk among adults with arthritis, a group of approximately 100 conditions affecting joints and surrounding tissues (most commonly osteoarthritis, fibromyalgia, gout, rheumatoid arthritis, and lupus) (1). Despite these benefits, the 54.6 million U.S. adults currently living with arthritis are generally less active than adults without arthritis, and only 36.2% of adults with arthritis are aerobically active (i.e., meet aerobic physical activity guidelines*) (2). Little is known about which physical activities adults with arthritis engage in. CDC analyzed 2019 Behavioral Risk Factor Surveillance System (BRFSS) data to examine the most common nonwork-related physical activities among adults with arthritis who reported any physical activity during the past month, nationally and by state. In 2019, 67.2% of adults with arthritis reported engaging in physical activity in the past month; among these persons, the most commonly reported activities were walking (70.8%), gardening (13.3%), and weightlifting (7.3%). In 45 U.S. states, at least two thirds of adults with arthritis who engaged in physical activity reported walking. Health care providers can help inactive adults with arthritis become active and, by encouraging physical activity and referring these persons to evidence-based physical activity programs, improve their health and quality of life.
286P Outcome of patients with HER2-positive brain metastatic breast cancer: A 10-year retrospective study
Authors: C. Bigot, H. Bischoff, I. Chambrelant, M.F. Demarchi, T. Petit, J.E. Kurtz, L. Pierard, C. Pflumio, M. Alt, C. Fischbach, M. Kalish Weindling, C. Lefevre, G. Noel, D. Cox, X. Pivot, P. Trensz, L. Bender
Journal: Annals of Oncology (2021)
DDX17‐regulated alternative splicing that produced an oncogenic isoform of PXN‐AS1 to promote HCC metastasis
Authors: Hong‐Zhong Zhou, Fan Li, Sheng‐Tao Cheng, Yong Xu, Hai‐Jun Deng, Da‐Yong Gu, Jin Wang, Wei‐Xian Chen, Yu‐Jiao Zhou, Min‐Li Yang, Ji‐Hua Ren, Lu Zheng, Ai‐Long Huang, Juan Chen
Journal: Hepatology (2021)

The mechanism underlying HCC metastasis remains unclear, many oncogenes are known to regulate this process. However, the role of alternative splicing (AS) in pro-metastatic HCC is poorly understood.By performing RNA sequencing on nine pairs of primary HCC tissues with extrahepatic metastasis (EHMH) and nine pairs of metastasis-free HCC (MFH) tissues, we depicted the AS landscape in HCC and found a higher frequency of AS events in EHMH compared with MFH. Moreover, 28 differentially expressed splicing regulators were identified in EHMH compared with MFH. Among these, DEAD-box RNA helicase 17 (DDX17) was significantly up-regulated in EHMH and was strongly associated with patient outcome. Functional studies indicated that DDX17 knockout inhibited the degradation of the extracellular matrix, and diminished the invasive ability of HCC cells. A significant reduction in lung metastasis induced by DDX17 deficiency was also demonstrated in a diethylnitrosamine-induced DDX17HKO mouse model. Mechanistically, high DDX17 induced intron 3 retention of PXN-AS1 and produced a transcript (termed PXN-AS1-IR3). The transcript PXN-AS1-IR3 acted as an important promoter of HCC metastasis by inducing MYC transcription activation via recruiting the complex of testis expressed 10 and p300 to the MYC enhancer region, which led to transcriptional activation of several metastasis-associated downstream genes. Finally, the PXN-AS1-IR3 level was significantly higher in serum and HCC tissues with extrahepatic metastasis.DDX17 and PXN-AS1-IR3 act as important metastatic promoters by modulating MYC signaling, suggesting that DDX17 and PXN-AS1-IR3 may be potential prognostic markers for metastatic HCC.
P-83 The efficacy of chemotherapy for gastric cancer with early recurrence during or after adjuvant S-1
Authors: K. Kumagai, S. Yagi, T. Yamaguchi, K. Nagashima, T. Nomura, M. Watanabe, R. Makuuchi, K. Kawakami, S. Otsuka, T. Matsushima, S. Kadowaki, S. Haruta, H. Cho, T. Yamada, N. Kakihara, Y. Imai, H. Fukunaga, Y. Saeki, S. Kanaji, N. Boku, M. Goto
Journal: Annals of Oncology (2021)
1757O Early reduction in ctDNA, regardless of best RECIST response, is associated with overall survival (OS) on tebentafusp in previously treated metastatic uveal melanoma (mUM) patients
Authors: A.N. Shoushtari, L. Collins, E. Espinosa, H. Sethi, S. Stanhope, S. Abdullah, A. Ikeguchi, K. Ranade, O. Hamid
Journal: Annals of Oncology (2021)
A unique technique for the removal of threaded biliary inside plastic stents
Authors: Masataka Yokode, Tomoaki Matsumori, Norimitsu Uza, Hirokazu Okada, Takeshi Kuwada, Masahiro Shiokawa, Hiroshi Seno
Journal: Endoscopy (2021)

Corrected by: Correction: A unique technique for the removal of threaded biliary inside plastic stentsEndoscopy eFirstDOI: 10.1055/a-1670-3562
1732MO Pembrolizumab and nintedanib for patients with advanced mesothelioma
Authors: F-X. Danlos, C. Baldini, A. Varga, S. Mouraud, B. Job, D. Letourneur, L. Cassard, D. Bredel, S. Laghouati, M. Texier, J. Adam, N. Droin, A. Parpaleix, N. Chaput, A. Rabeau, G. Zalcman, D. Planchard, C. Massard, J-C. Soria, A. Marabelle
Journal: Annals of Oncology (2021)
Global distribution of human hookworm species and differences in their morbidity effects: a systematic review
Authors: Archie C A Clements, Kefyalew Addis Alene
Journal: The Lancet Microbe (2021)

The global distribution and morbidity effects for each specific hookworm species is unknown, which prevents implementation of the optimum intervention for local hookworm control. We did two systematic reviews of studies on the proportion of hookworm isolates of each species and genus by region of the world and associations between hookworm species-specific infections and morbidity outcomes, particularly severe anaemia. Necator americanus and Ancylostoma spp were present in all regions of the world, although at different ratios. No clear evidence was found for the differential morbidity effects of different hookworm species. Diagnostic methods that differentiate between hookworm species, including molecular methods, need to be developed for widespread use in control programmes to elucidate key features of hookworm epidemiology and control.
Abstract 2980: Elevated Interleukin-6 Levels are Independently Associated with Neurocardiogenic Injury
Authors: Alexander Kopelnik, Sirisha Yarlagadda, Ludmila Pawlikowska, Nerissa Ko, Michael T Lawton, Pui-Yan Kwok, Alan Wu, William L Young, Jonathan G Zaroff
Journal: Circulation (2006)

Introduction: Inflammation and inflammatory cytokines (IC) have been associated with the development of several cardiovascular diseases such as atherosclerosis, acute coronary syndromes, and heart ...
1093TiP An open-label, multicenter, phase I/II clinical trial of RP1 as a single agent and in combination with nivolumab in patients with solid tumors [IGNYTE]
Authors: F. Aroldi, M.R. Middleton, J.J. Sacco, M.M. Milhem, B.D. Curti, A.M. VanderWalde, S.L. Baum, A. Samson, J. Chesney, J. Niu, T.D. Rhodes, T.L. Bowles, A. Olsson-Brown, D.E. Laux, P.K. Bommareddy, L. Menezes, S. Samakoglu, A. Pirzkall, R.S. Coffin, K.J. Harrington
Journal: Annals of Oncology (2021)
Abstract P023: Subclinical Inflammation and Weight Change in Middle-aged and Older Adults
Authors: Emmanuel M Quaye, Elizabeth Selvin, Chiadi Ndumele, Kunihiro Matsushita, Karen Bandeen-Roche, June Stevens, Priya Palta, Lynne Wagenknecht, Josef Coresh
Journal: Circulation (2016)

Introduction: C-reactive protein (CRP) is a marker of inflammation that is associated with obesity; inflammation also plays a role in the onset of cachexia. CRP and its relationship with weight change (gain and loss) is less well understood, particularly in studies including both middle-aged and older adults. Hypothesis: Elevated CRP is associated with both subsequent body mass index (BMI) gain and even more strongly associated with subsequent BMI loss in middle-aged and older adults. Methods: We analyzed BMI (kg/m2) changes in 11,136 ARIC participants followed since Visit 2 (1990 - 92) when CRP was measured (Table 1). BMI change between study visits was categorized as stable (&lt;+/-2 kg/m2, average of &lt;+/-13 lbs.), gain or loss (&gt;+/-2 kg/m2). High sensitivity CRP (hs-CRP) was classified according to AHA/CDC guidelines for CVD risk. Multinomial logistic regression was used to characterize the association of BMI change with categories of hs-CRP. Results: Table 1 shows BMI change and its associations with categories of hs-CRP. Multinomial logistic regression demonstrated that individuals who had high CRP in midlife at visit 2 had increased odds of both subsequent BMI gain and loss both in the next 6 years (visit 2 to visit 4) and in the following 15 years (visit 4 to visit 5). Inflammation in late midlife (visit 4, median age: 62) was also predictive of subsequent BMI gain and loss (to visit 5, median age: 75). Similar associations were seen after further adjustment for diabetes, hypertension, physical activity and smoking (p&lt;0.05). Conclusion: Elevated CRP was associated with subsequent BMI gain, but was more strongly associated with subsequent BMI loss in both midlife and older age. These findings suggest that inflammation is a marker associated with weight change that may help distinguish between healthy and unhealthy weight loss in middle-aged and older adults.
Efficient production of human neutrophils from iPSCs that prevent murine lethal infection with immune cell recruitment
Authors: Masashi Miyauchi, Yusuke Ito, Fumio Nakahara, Toshiya Hino, Fumi Nakamura, Yuki Iwasaki, Taiki Kawagoshi, Junji Koya, Akihide Yoshimi, Shunya Arai, Yuki Kagoya, Mineo Kurokawa
Journal: Blood (2021)
989P Autoimmune panels as predictors of immune-related adverse events (irAEs) in patients (pts) treated with immune checkpoint inhibitors (ALERT)
Authors: S. Genta, N. Yee, S. Keshavarzi, A. Heirali, A.R. Hansen, L.L. Siu, S. Saibil, L-A. Stayner, M. Yanekina, T. Pimentel Muniz, M. Vilbert, P. Bedard, A.R. Abdul Razak, B. Coburn, A. Chruscinski, A. Spreafico
Journal: Annals of Oncology (2021)
PS1295 IRON IN THE HUMAN HEARTS: DISTRIBUTION AND ASSOCIATION WITH R2<sup>∗</sup> VALUES BY CMR
Authors: A. Meloni, A. Maggio, V. Positano, A. Angelini, M.C. Putti, E. Maresi, A. Pucci, C. Basso, F. Leto, M. Perazzolo, L. Pistoia, A. Pepe
Journal: HemaSphere (2019)

Background: T2 ∗ (or R2 ∗ = 1000/T2 ∗ ) cardiac magnetic resonance (CMR) allows the non‐invasive and reproducible measurement of myocardial iron and has been established as fundamental to the best practice management of iron loaded patients to improve morbidity and mortality. Aims: In the present study we calibrated cardiac R2 ∗ values against myocardial tissue ‐measured iron concentration by using a segmental approach and we assessed the distribution and regional variations in iron distribution. Methods: Five hearts of patients with thalassemia were donated after death (N = 4) or cardiac transplantation (N = 1) to the CoreLab of the MIOT (Myocardial Iron Overload in Thalassemia) Network. A multislice multiecho T2 ∗ approach was adopted. After CMR, used as guidance, the heart was cut in three short‐axis slice and each slice was cut into different equiangular segments accordingly with AHA segmentation and differentiated into endocardial and epicardial layer, the same ones in which the T2 ∗ was assessed. Tissue iron concentration in the segments was measured with an atomic absorption spectrometer. Results: 55 samples were used since it was possible to analyze all the 16 samples only from two hearts due to medical‐forensic reasons. The mean iron concentration in all samples was 4.71 ± 4.67 mg/g dw. Segmental iron levels ranged from 0.24 to 13.78 mg/g dw. Mean iron concentration was significantly higher in the epicardial than in the endocardial layer (5.99 ± 6.01 mg/g dw vs 4.84 ± 4.87 mg/g dw; P = 0.042). The coefficient of variability (CoV) of iron for myocardial segments ranged from 8.08% to 24.54%, with a mean value for all patients of 13.49 ± 6.93%. Four different main circumferential regions (anterior, septal, inferior and lateral) were defined. A circumferential heterogeneity was noted, with more iron observed in the anterior region, followed by the inferior region. The heterogeneity in circumferential iron concentration expressed as percentage deviation of the regions from the global value is shown in the Figure 1A. A strong linear correlation (R‐square = 0.956) was found by plotting ln(R2 ∗ ‐ROI) and ln[Fe] with a slope s = 0.654 (95% confidence intervals‐CI = 0.616–0.693) and intercept i = 4.216 (95% CI = 4.150–4.281) (Figure 1B). The linear relation was converted to the calibration curve: [Fe] = 0.001591 X (R2 ∗ ) 1.529 . Summary/Conclusion: Our data suggests an heterogeneous pattern of cardiac iron distribution with higher epicardial layer involvement. Heart R2 ∗ provided a robust calibration against chemically assayed cardiac iron, further validating the current clinical practice of monitoring cardiac iron in vivo by CMR. image
Dissociable effects of APOE ε4 and β-amyloid pathology on visual working memory
Authors: Kirsty Lu, Jennifer M. Nicholas, Yoni Pertzov, John Grogan, Masud Husain, Ivanna M. Pavisic, Sarah-Naomi James, Thomas D. Parker, Christopher A. Lane, Ashvini Keshavan, Sarah E. Keuss, Sarah M. Buchanan, Heidi Murray-Smith, David M. Cash, Ian B. Malone, Carole H. Sudre, William Coath, Andrew Wong, Susie M. D. Henley, Nick C. Fox, Marcus Richards, Jonathan M. Schott, Sebastian J. Crutch
Journal: Nature Aging (2021)
The Effect of Discontinuing Continuous Glucose Monitoring in Adults With Type 2 Diabetes Treated With Basal Insulin
Authors: Grazia Aleppo, Roy W. Beck, Ryan Bailey, Katrina J. Ruedy, Peter Calhoun, Anne L. Peters, Rodica Pop-Busui, Athena Philis-Tsimikas, Shichun Bao, Guillermo Umpierrez, Georgia Davis, Davida Kruger, Anuj Bhargava, Laura Young, John B. Buse, Janet B. McGill, Thomas Martens, Quang T. Nguyen, Ian Orozco, William Biggs, K. Jean Lucas, William H. Polonsky, David Price, Richard M. Bergenstal, Thomas Martens, Anders Carlson, Richard M. Bergenstal, Sharon Chambers, Shoua Yang, Laura Young, John Buse, M. Sue Kirkman, Alexander Kass, Rachael Fraser, Davida Kruger, Terra Cushman, Georgia Davis, Clementina Ramos, Guillermo Umpierrez, Anne L. Peters, Maria Magar, Martha Walker, Sara Serafin-Dokhan, Janet B. McGill, Maamoun Salam, Stacy Hurst, Mary Jane Clifton, Grazia Aleppo, Jelena Kravarusic, Anupam Bansal, Candice Fulkerson, Rodica Pop-Busui, Lynn Ang, Caroline Richardson, Kara Mizokami-Stout, Jake Reiss, Virginia Leone, Anuj Bhargava, Kirstie Stifel, Athena Philis-Tsimikas, George Dailey, Amy Change, James McCallum, Maria Isabel Garcia, Shichun Bao, Dianne Davis, Cynthia Lovell, Connie Root, William Biggs, Freida Toler, Lori Wilhelm, Robin Eifert, Lorena Murguia, Becky Cota, Quang T. Nguyen, Loida Nguyen, Randie Lipski, Ian Orozco, Mary Katherine Lawrence, Adelle Fournier, Matthew Carter, K. Jean Lucas, Stephanie Hoover, Roy W. Beck, Katrina J. Ruedy, Peter Calhoun, Ryan Bailey, Nathan Cohen, Thomas Mouse, Jessica Rusnak, Tiffany Campos, David Price, Nelly Njeru, Tom Arant, Stayce E. Beck, Andrew Balo
Journal: Diabetes Care (2021)

OBJECTIVE To explore the effect of discontinuing continuous glucose monitoring (CGM) after 8 months of CGM use in adults with type 2 diabetes treated with basal without bolus insulin. RESEARCH DESIGN AND METHODS This multicenter trial had an initial randomization to either real-time CGM or blood glucose monitoring (BGM) for 8 months followed by 6 months in which the BGM group continued to use BGM (n = 57) and the CGM group was randomly reassigned either to continue CGM (n = 53) or discontinue CGM with resumption of BGM for glucose monitoring (n = 53). RESULTS In the group that discontinued CGM, mean time in range (TIR) 70–180 mg/dL, which improved from 38% before initiating CGM to 62% after 8 months of CGM, decreased after discontinuing CGM to 50% at 14 months (mean change from 8 to 14 months −12% [95% CI −21% to −3%], P = 0.01). In the group that continued CGM use, little change was found in TIR from 8 to 14 months (baseline 44%, 8 months 56%, 14 months 57%, mean change from 8 to 14 months 1% [95% CI −11% to 12%], P = 0.89). Comparing the two groups at 14 months, the adjusted treatment group difference in mean TIR was −6% (95% CI −16% to 4%, P = 0.20). CONCLUSIONS In adults with type 2 diabetes treated with basal insulin who had been using real-time CGM for 8 months, discontinuing CGM resulted in a loss of about one-half of the initial gain in TIR that had been achieved during CGM use.
US hospitals tighten security as violence against staff surges during pandemic
Authors: Owen Dyer
Journal: BMJ (2021)

Hospitals officials in the United States say that their doctors and nurses are seeing more assaults and threats than ever before as the covid pandemic generates new friction points between patients, staff, and families.

Cox Medical Center Branson in southwest Missouri has said that it will issue about 400 panic buttons to its staff after measuring a dramatic increase in violence from 2019 to 2020, “with the pandemic greatly compounding the issue.”

The number of assaults on staff increased from 40 to 123, while reported injuries jumped from 17 to 78, Cox Branson’s patient safety facilitator, Angie Smith, told the Ozarks First news website. “To see that these numbers are doubling, tripling, and continuing to go up, especially the physical, it’s very unnerving,” she said.

Throughout the Cincinnati region in southern …
Minute gastric adenocarcinoma of the fundic-gland type with submucosal invasion
Authors: Tsutomu Takeda, Hiroya Ueyama, Kuang-I Fu, Satoshi Murata, Akihito Nagahara
Journal: Endoscopy (2021)

A 64-year-old woman without Helicobacter pylori infection underwent an esophagogastroduodenoscopy during a health examination. A 2-mm flat lesion (0-IIb) with faded color and harboring a regular arrangement of collecting venules was detected at the greater curvature of the gastric fundus. Narrow-band imaging (NBI) showed a distinct whitish lesion. Magnifying endoscopy with NBI revealed a regular microsurface and microvascular pattern without a demarcation line, and a noncancer diagnosis was made [1]. However, as the endoscopic features on white-light imaging still strongly suggested neoplastic lesion in the background of mucosa not infected by H. pylori, a biopsy was taken. Histologically, a gastric adenocarcinoma resembling fundic gland cells with submucosal invasion was seen ([Fig. 1]). A pathological diagnosis of gastric adenocarcinoma of the fundic-gland type [2] [3] was further confirmed by immunohistochemical staining.
308P FDG-PET/CT versus CE-CT for response monitoring in metastatic breast cancer: A prospective comparative study
Authors: M. Vogsen, F. Harbo, N.M. Jakobsen, H.J. Nissen, S.E. Dahlsgaard-Wallenius, O. Gerke, J.D. Jensen, J.T. Asmussen, A.M.B. Jylling, P-E. Braad, W. Vach, M. Ewertz, M.G. Hildebrandt
Journal: Annals of Oncology (2021)
IMpower150 Final Exploratory Analyses for Atezolizumab Plus Bevacizumab and Chemotherapy in Key NSCLC Patient Subgroups With EGFR Mutations or Metastases in the Liver or Brain
Authors: Naoyuki Nogami, Fabrice Barlesi, Mark A. Socinski, Martin Reck, Christian A. Thomas, Federico Cappuzzo, Tony S.K. Mok, Gene Finley, Joachim G. Aerts, Francisco Orlandi, Denis Moro-Sibilot, Robert M. Jotte, Daniil Stroyakovskiy, Liza C. Villaruz, Delvys Rodríguez-Abreu, Darren Wan-Teck Lim, David Merritt, Shelley Coleman, Anthony Lee, Geetha Shankar, Wei Yu, Ilze Bara, Makoto Nishio
Journal: Journal of Thoracic Oncology (2021)
LBA56 Perioperative or only adjuvant nab-paclitaxel plus gemcitabine for resectable pancreatic cancer: Results of the NEONAX trial, a randomized phase II AIO study
Authors: T. Seufferlein, W. Uhl, H. Algül, H. Friess, M. Kornmann, A.O. König, M. Ghadimi, T.M. Gress, M.P. Lutz, K. Wille, C. Schimanski, V. Kunzmann, A. Berger, J. Schuhbaur, L. Perkhofer, L. Blome, A. Tannapfel, M.A. Tempero, A. Reinacher-Schick, T.J. Ettrich
Journal: Annals of Oncology (2021)
Lupus erythematosus and epidermal necrolysis: a case series of 16 patients
Authors: O. Gaudin, B. Milpied, B. Papouin, S. Hüe, N. Ortonne, E. Régnier, P. Wolkenstein, O. Chosidow, N. de Prost, S. Ingen‐Housz‐Oro
Journal: British Journal of Dermatology (2021)
1364TiP Phase II single-arm trial of safety, antitumor activity, and pharmacokinetics of tusamitamab ravtansine (SAR408701) plus ramucirumab in CEACAM5-positive, metastatic, non-squamous, non-small cell lung cancer progressing on platinum-based chemotherapy and immunotherapy
Authors: B.C. Cho, C. Aguado de la Rosa, L. Vilà, D. Isla, J. Oliveira, J. de Castro Carpeno, A. Tomova, T.M. Kim, A. Blasco Cordellat, A-L. Bauchet, C. Soufflet, S. Bensfia, G. Dy
Journal: Annals of Oncology (2021)